March 28, 2024

Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations

Background. Asthma exacerbations are frightening for patients and are occasionally fatal. We tested the concept that a plan for patients to manage their asthma (self-management plan), which included a temporary quadrupling of the dose of inhaled glucocorticoids when asthma control started to deteriorate, would reduce the incidence of severe asthma exacerbations among adults and adolescents with asthma.

Methods

We conducted a pragmatic, unblinded, randomized trial involving adults and adolescents with asthma who were receiving inhaled glucocorticoids, with or without add-on therapy, and who had had at least one exacerbation in the previous 12 months.

We compared a self-management plan that included an increase in the dose of inhaled glucocorticoids by a factor of 4 (quadrupling group) with the same plan without such an increase (non-quadrupling group), over a period of 12 months. The primary outcome was the time to a first severe asthma exacerbation, defined as treatment with systemic glucocorticoids or an unscheduled health care consultation for asthma.

Results

A total of 1922 participants underwent randomization, of whom 1871 were included in the primary analysis. The number of participants who had a severe asthma exacerbation in the year after randomization was 420 (45%) in the quadrupling group as compared with 484 (52%) in the non-quadrupling group, with an adjusted hazard ratio for the time to a first severe exacerbation of 0. 81 (95% confidence interval, 0. 71 to 0. 92; P=0. 002).

The rate of adverse effects, which were related primarily to local effects of inhaled glucocorticoids, was higher in the quadrupling group than in the non-quadrupling group.

Conclusions

In this trial involving adults and adolescents with asthma, a personalized self-management plan that included a temporary quadrupling of the dose of inhaled glucocorticoids when asthma control started to deteriorate resulted in fewer severe asthma exacerbations than a plan in which the dose was not increased.

Funded by the Health Technology Assessment Programme of the National Institute for Health Research; Current Controlled Trials number, ISRCTN15441965.

8 thoughts on “Quadrupling Inhaled Glucocorticoid Dose to Abort Asthma Exacerbations

  1. Currently it sounds like Drupal is the best blogging platform available right now. (from what I’ve read) Is that what you’re using on your blog?

  2. Have you ever thought about creating an ebook or guest authoring on other websites?
    I have a blog based on the same subjects you discuss and would really like to have you share some stories/information. I know my audience would value your work.
    If you are even remotely interested, feel free to shoot me an email.

  3. It’s actually a great and useful piece of information. I’m glad that you simply shared this helpful information with us.
    Please keep us informed like this. Thanks for sharing.

  4. I was recommended this blog by my cousin. I’m not positive whether this publish is written through him as nobody else recognise such specified approximately my problem.
    You’re amazing! Thanks!

  5. Hmm it looks much like your site ate my first comment (it had been super long) so I guess I’ll just sum it what I wrote and say, I’m thoroughly enjoying your website. I too am an aspiring blog writer but I’m still a new comer to the whole thing. Have you got any suggestions for newbie blog writers?
    I’d certainly appreciate it.

  6. My spouse and I stumbled right here different web address and thought I might check things out. I love the things i see so i am just just following you.
    Look forward to exceeding your internet page repeatedly.

Leave a Reply

Your email address will not be published. Required fields are marked *